纤溶酶治疗急性脑梗死49例临床疗效分析  

Curative efficacy of fibrinolysin in the treatment of cerebral infarction

作　　者：赵明[1] 张永利[1] 李梅香[1] 

机构地区：[1]新乡医学院第二附属医院,河南新乡453002

出　　处：《中原医刊》2007年第10期30-31,共2页Central Plains Medical Journal

摘　　要：目的观察纤溶酶治疗急性脑梗死的疗效。方法将97例急性脑梗死患者随机分为两组;研究组49例,对照组48例;研究组每日用纤溶酶200 U静脉滴注;对照组用复方丹参静脉滴注。根据脑卒中患者神经功能缺损评分标准评判治疗效果。结果观察组总有效率达87.8%,对照组达66.7%,二组比较差异有统计学意义（P〈0.05）。结论纤溶酶静脉溶栓治疗急性脑梗死,临床效果确切,无明显不良反应,值得进一步推广应用。Objective To explore the curative effect of fibrinolysin on the cerebral infarction. Methods Ninety- seven patients with acute cerebral infarction were randomly divided into two groups. In experimental group, forty -nine cases were intravenously 200 U fibrinolysin once a day;forty -eight cases in control group were administered composite salvia miltiorrhiza injection. The clinical curative effect assessed by Chinese scale of clinical neurologic impairment of stroke patients. Results Effective rate was 87.8% in experimental group, but in control group was 66.7%. The curative effect in experimental group had a remarkable advantage compared with that of the control group （ P 〈 0.05）. Conclusion The curative effect of fibrinolysin on the cerebral infarction is definite and it is safe to administer fibrinolysin.

关 键 词：脑梗死 纤溶酶 疗效 

分 类 号：R74[医药卫生—神经病学与精神病学]